07:00 , Nov 1, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy Topoisomerase IIb (TOP2B) Mouse studies suggest TOP2B expression could help predict the risk of doxorubicin-induced cardiomyopathy. Cardiomyocytes from doxorubicin-treated mice with cardiac-specific Top2b...